NFKB1 and inflammatory bowel disease: In experimental models of inflammatory bowel disease (IBD), MSC exosomes have been shown to dampen dendritic cell activation, suppress pro-inflammatory cytokine release, and stimulate intestinal regeneration by activating receptors such as FXR and modulating NF-κB–mediated pathways [85].